— Know what they know.
Not Investment Advice

PRTA NASDAQ

Prothena Corporation plc
1W: -4.6% 1M: -12.2% 3M: +4.3% YTD: +2.3% 1Y: +29.1% 3Y: -87.2% 5Y: -59.0%
$9.83
+0.42 (+4.46%)
 
Weekly Expected Move ±8.3%
$8 $9 $10 $11 $11
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $514.6M mcap · 42M float · 1.24% daily turnover · Short 68% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$10M -92.8% ▼
5Y CAGR: +62.6%
Gross Profit
$6M -95.6% ▼
Operating Income
-$185M -19.4% ▼
Net Income
-$244M -99.6% ▼
EPS (Diluted)
$-4.53 -99.6% ▼
EBITDA
-$197M -28.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$201M$54M$91M$135M$10M
YoY Growth+23414.3%-73.1%+69.5%+47.9%-92.8%
Cost of Revenue$0$0$0$0$4M
Gross Profit$201M$54M$91M$135M$6M
Gross Margin100.0%100.0%100.0%100.0%61.8%
R&D Expenses$82M$136M$221M$223M$135M
SG&A Expenses$46M$50M$62M$67M$59M
Operating Expenses$129M$185M$282M$290M$191M
Operating Income$72M-$132M-$191M-$155M-$185M
Operating Margin35.9%-244.1%-209.1%-114.4%-1905.8%
Interest Expense$0$0$0$0$0
Income Before Tax$72M-$126M-$160M-$129M-$201M
Tax Expense$5M-$9M-$13M-$7M$43M
Net Income$67M-$117M-$147M-$122M-$244M
Net Margin33.4%-217.0%-160.9%-90.5%-2520.6%
EPS (Diluted)$1.38$-2.47$-2.76$-2.27$-4.53
EBITDA$73M-$131M-$190M-$154M-$197M
Shares Outstanding48M47M53M54M54M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms